LEADER 04492nam 22005534a 450 001 996206284903316 005 20230120010521.0 010 $a1-4377-1969-4 035 $a(CKB)1000000000798753 035 $a(EBL)1429655 035 $a(OCoLC)861539044 035 $a(SSID)ssj0000483384 035 $a(PQKBManifestationID)11300081 035 $a(PQKBTitleCode)TC0000483384 035 $a(PQKBWorkID)10572577 035 $a(PQKB)11023042 035 $a(MiAaPQ)EBC1429655 035 $a(EXLCZ)991000000000798753 100 $a20090115d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClinical management of thyroid disease$b[electronic resource] /$fedited by Fredric E. Wondisford, Sally Radovick 210 $aPhiladelphia $cSaunders/Elsevier$dc2009 215 $a1 online resource (435 p.) 300 $aDescription based upon print version of record. 311 $a1-336-22990-X 311 $a1-4160-4745-X 320 $aIncludes bibliographical references and index. 327 $aFront Cover; Clinical Management of Thyroid Disease; Copyright Page; Contributors; Contents; PART I Normal Thyroid Axis; Section A Anatomy; Chapter 1 Anatomy of theHypothalamic-Pituitary-Thyroid Axis; HYPOTHALAMUS AND PITUITARY; THYROID GLAND; References; Chapter 2 Thyroid Development; MORPHOLOGIC ASPECTS; DIFFERENTIATION OF THYROID FOLLICULAR CELLS; MOLECULAR GENETICS; CONCLUSIONS; References; Section B THYROID HORMONE; Chapter 3 Thyroid Hormone Synthesis; IODIDE UPTAKE BY THE SODIUM-IODIDESYMPORTER; IODIDE EFFLUX; THYROGLOBULIN; HYDROGEN PEROXIDE GENERATING SYSTEM 327 $aDEFECTS IN THYROID HORMONE SYNTHESISReferences; Chapter 4 Thyroid Hormone Action; THYROID HORMONE METABOLISM AND TRANSPORT; THYROID HORMONE RECEPTORS; THYROID HORMONE RESPONSE ELEMENTS; NONGENOMIC EFFECTS OF THYROID HORMONES; THYROID HORMONE ANALOGUES; CONCLUSIONS; References; Chapter 5 Thyroid Hormone Metabolism; DEIODINASES: THIOREDOXINFOLD-CONTAINING PROTEINS; DEIODINASES IN ILLNESS; References; Section C THYROID AXIS; Chapter 6 Role of Thyrotropin-Releasing Hormone in Thyroid Axis Regulation; THYROTROPIN-RELEASING HORMONE: STRUCTURE AND FUNCTION 327 $aREGULATION OF THYROTROPIN-RELEASING HORMONESUMMARY; References; Chapter 7 Thyroid-Stimulating Hormone and Thyroid-StimulatingHormone Receptor; THYROTROPIN; THYROTROPIN RECEPTOR; References; Part II Pediatric Thyroid; Chapter 8 Screening for Congenital Disease; SCREENING STRATEGIES; CONFIRMATIONAL DIAGNOSIS; THYROID HORMONE REPLACEMENT THERAPY; SPECIAL CONSIDERATIONS; References; Chapter 9 PERMANENT PRIMARY CONGENITAL HYPOTHYROIDISM; PERMANENT PRIMARY CONGENITAL HYPOTHYROIDISM; CENTRAL CONGENITAL HYPOTHYROIDISM; References; Chapter 10 Hypothyroidism 327 $aReferencesChapter 14 Toxic Nodular Goiter:Toxic Adenoma andToxic Multinodular Goiter; TOXICADENOMA,TOXIC MULTINODULAR GOITER AND AUTONOMOUS THYROID FUNCTION; OVERVIEW OF MOLECULAR PATHOGENESIS; EPIDEMIOLOGY; CAUSE AND PATHOGENESIS; CLINICAL FEATURES; DIAGNOSIS; TREATMENT; CLINICAL COURSE AND PREVENTION; References; Chapter 15 Thyroid-StimulatingHormone-Induced Hyperfunction; PATHOPHYSIOLOGY; CLINICAL FEATURES; DIAGNOSTIC PROCEDURES; DIFFERENTIAL DIAGNOSIS; TREATMENT; References; Chapter 16 Hyperthyroidism and Trophoblastic Disease; HUMAN CHORIONIC GONADOTROPIN 327 $aDISORDERS RESULTING FROM INCREASED HUMAN CHORIONIC GONADOTROPIN CONCENTRATION 330 $aClinical Management of Thyroid Disease is an exciting new book edited by Fredric Wondisford, MD-developer of the revolutionary new drug, Thyrotropin-and Sally Radovick, MD, with contributions from experts in the field. It fulfills the niche of a succinct, clinical resource to help you translate research into practice. This full-color volume offers valuable information on thyroid cancer and non-cancerous lesions, the effect of drugs on thyroid function, genetic disorders, and more in an accessible, easy-to-read consistent format.Presents the expertise of authors and editorial staff comp 606 $aThyroid gland$xDiseases$vTextbooks 615 0$aThyroid gland$xDiseases 676 $a616.4/4 701 $aWondisford$b Fredric E$0847354 701 $aRadovick$b Sally$01011332 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996206284903316 996 $aClinical management of thyroid disease$92342586 997 $aUNISA